Credit Suisse Ag Inhibrx, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Inhibrx, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 18,561 shares of INBX stock, worth $293,263. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,561
Previous 19,742
5.98%
Holding current value
$293,263
Previous $750,000
13.6%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INBX
# of Institutions
2Shares Held
25.3KCall Options Held
0Put Options Held
0About Inhibrx, Inc.
- Ticker INBX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,057,700
- Market Cap $617M
- Description
- Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...